announced that it has received final approval for its Clobetasol Propionate Lotion, 0.05% from the United States Food and Drug Administration (FDA)... ...http://feedproxy.google.com/~r/feedburner/HlRy/~3/gki79XJMipQ/storyShow.php
Posted by Equitymaster Global financial markets ended the week on a flat note despite North Korea once again threatening to test a hydrogen bomb in... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/Z0nXMg2gI6k/tm.asp
Global healthcare provider Zydus Cadila on Saturday said it received approval from the US Federal Drug Authority (USFDA) to market Amlodipine and... ...http://www.business-standard.com/article/news-ians/zydus-hypertension-drug-gets-us-regulatory-nod-117092300820_1.html
Posted by Equitymaster Asian stocks markets are higher in morning trade as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.83%... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/UuVbOi1q_YY/tm.asp
Axis Capital has upgraded the rating on stock to buy and hiked its target price to Rs 1,080 from Rs 625 per share, following increase in earnings... ...http://www.moneycontrol.com/news/buzzing-stocks/divis-labs-jumps-5-as-axis-capital-upgrades-hikes-target-sharply-post-usfda-audit_9722901.html
SORBEAD INDIA is offering a wide...
Miocon is pleased to introduce...